[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Intrahepatic recurrence of hepatocellular carcinoma after resection: an update

M Tampaki, GV Papatheodoridis… - Clinical Journal of …, 2021 - Springer
Hepatocellular carcinoma recurrence occurs in 40–70% of patients after hepatic resection.
Despite the high frequency of hepatocellular cancer relapse, there is no established …

Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells

J Zhang, W Shan, T Jin, G Wu, X Xiong, H Jin… - Journal of translational …, 2014 - Springer
Objective We previously confirmed that propofol directly inhibited the viability, proliferation,
and invasiveness of hepatocellular carcinoma cells in vitro. In this study, we investigated the …

Nomograms for predicting hepatocellular carcinoma recurrence and overall postoperative patient survival

L Ma, K Deng, C Zhang, H Li, Y Luo, Y Yang… - Frontiers in …, 2022 - frontiersin.org
Background Few studies have focused on the prognosis of patients with hepatocellular
carcinoma (HCC) of Barcelona Clinic Liver Cancer (BCLC) stage 0‒C in terms of early …

The feasibility of third or more repeat hepatectomy for recurrent hepatocellular carcinoma

Y Mise, K Hasegawa, J Shindoh, T Ishizawa… - Annals of …, 2015 - journals.lww.com
Objectives: To investigate the feasibility and prognostic benefits of third or more
hepatectomy (third or more Hx) for recurrent hepatocellular carcinoma. Background: Second …

[HTML][HTML] Comparison on the efficacy and prognosis of different strategies for intrahepatic recurrent hepatocellular carcinoma: a systematic review and Bayesian …

J Zheng, J Cai, L Tao, MA Kirih, Z Shen, J Xu… - International Journal of …, 2020 - Elsevier
Background Hepatocellular carcinoma (HCC) has a high rate of recurrence. This network
meta-analysis aimed to compare the oncological prognosis of the conventional treatments …

2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association … - Korean Journal of …, 2019 - synapse.koreamed.org
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[PDF][PDF] Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: an intent‐to‐treat analysis

C Lim, H Shinkawa, K Hasegawa… - Liver …, 2017 - Wiley Online Library
The salvage liver transplantation (LT) strategy was conceived for initially resectable and
transplantable hepatocellular carcinoma (HCC) to obviate upfront transplantation, with …